MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TFX made $548,262K in revenue. -$8,154K in net income. Net profit margin of -1.49%.

Income Overview

Revenue
$548,262K
Net Income
-$8,154K
Net Profit Margin
-1.49%
EPS
-$0.18
Unit: Thousand (K) dollars
Revenue Breakdown
    • Vascular Access
    • Interventional
    • Surgical
Revenue Breakdown
    • Americas Segment
    • EMEASegment
    • Asia Segment

Income Statement
2026-03-31
2025-12-31
2025-09-28
2025-06-29
Net revenues
548,262 -401,866 913,021 780,889
Cost of goods sold
240,836 -250,454 461,379 349,804
Gross profit
307,426 -151,412 451,642 431,085
Selling, general and administrative expenses
226,012 614 281,764 215,081
Research and development expenses
44,386 12,628 57,228 38,521
Pension settlement charge
-0* 0 0
Goodwill impairment
--403,925 -
Restructuring charges, separation costs and impairment charges
16,845 -7,119 117,623 22,172
Gain on sale of assets and business
-403,925* --
Income from continuing operations before interest and taxes
20,183 246,390 -408,898 155,311
Interest expense
25,718 28,130 31,841 21,708
Interest income
1,708 680 2,163 1,643
(loss) income from continuing operations before taxes
-3,827 218,940 -438,576 135,246
Taxes on income from continuing operations
1,011 -30,779 -29,699 12,662
(loss) income from continuing operations
-4,838 249,719 -408,877 122,584
Net revenues
283,817 ---
Cost of goods sold
146,907 ---
Selling, general and administrative expenses
66,187 ---
Research and development expenses
14,268 ---
Restructuring charges, separation costs and impairment charges
59,148 ---
Interest expense
54 ---
Interest income
104 ---
Operating (loss) income from discontinued operations
-2,643 -1,097,017 -20 -4
Taxes on operating income from discontinued operations
673 -132,968 -5 0
(loss) income from discontinued operations
-3,316 -964,049 -15 -4
Net (loss) income
-8,154 -714,330 -408,892 122,580
Basic EPS
-0.18 -16.161 -9.24 2.77
Diluted EPS
-0.18 -16.088 -9.24 2.77
Basic Average Shares
44,257,000 44,200,000 44,237,000 44,269,000
Diluted Average Shares
44,257,000 44,401,000 44,237,000 44,332,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Vascular Access$236,812K (29.85%↑ Y/Y)Interventional$204,656K (48.78%↑ Y/Y)Surgical$106,794K (0.95%↑ Y/Y)Net (loss) income-$8,154K (-108.58%↓ Y/Y)Net revenues$548,262K (-21.75%↓ Y/Y)(loss) income fromcontinuing operations-$4,838K (-105.09%↓ Y/Y)(loss) income fromdiscontinued operations-$3,316K (-3150.98%↓ Y/Y)Gross profit$307,426K (-21.06%↓ Y/Y)Cost of goods sold$240,836K (-22.62%↓ Y/Y)(loss) income fromcontinuing operations...-$3,827K (-103.51%↓ Y/Y)Taxes on income fromcontinuing operations$1,011K (-92.69%↓ Y/Y)Operating (loss) incomefrom discontinued...-$2,643K (-1887.22%↓ Y/Y)Taxes on operatingincome from...$673K (2270.97%↑ Y/Y)Income from continuingoperations before interest...$20,183K (-83.93%↓ Y/Y)Interest income$1,708K (-10.90%↓ Y/Y)Net revenues$283,817K (-59.49%↓ Y/Y)Selling, general andadministrative expenses$226,012K (1.48%↑ Y/Y)Research and developmentexpenses$44,386K (21.93%↑ Y/Y)Restructuring charges,separation costs and...$16,845K (254.26%↑ Y/Y)Interest income$104K (-94.57%↓ Y/Y)Interest expense$25,718K (38.69%↑ Y/Y)Cost of goods sold$146,907K (-52.80%↓ Y/Y)Selling, general andadministrative expenses$66,187K (-70.28%↓ Y/Y)Restructuring charges,separation costs and...$59,148K (1143.91%↑ Y/Y)Research and developmentexpenses$14,268K (-60.81%↓ Y/Y)Interest expense$54K (-99.71%↓ Y/Y)

TFX_BIG-svg

TELEFLEX INC (TFX)

TFX_BIG-svg

TELEFLEX INC (TFX)